Ribonucleic Acid News and Research

RSS
Prior COVID-19 protects against subsequent infections

Prior COVID-19 protects against subsequent infections

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

Booster vaccine provides similar protection in SARS-CoV-2 naive and convalescent individuals

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

4% patients with COVID-19 shed fecal viral RNA 10 months after diagnosis

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

Efficacy of vaccination against SARS-CoV-2 Omicron BA.1 and BA.2 sublineages in Sweden

The diversity of transcriptional targets between four different coronavirus nsp1 proteins

The diversity of transcriptional targets between four different coronavirus nsp1 proteins

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

Study demonstrates that a low-dose, bivalent, unmodified mRNA vaccine against SARS-CoV-2 is highly efficacious

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

Booster dose of BNT162b2 mRNA vaccine induces a high cross-neutralizing response against SARS-CoV-2 variants

COVID-19 mRNA vaccine protects against ICU admission for 1 year

COVID-19 mRNA vaccine protects against ICU admission for 1 year

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

CRISPR-based detection of SARS-CoV-2 RNA directly from patient swabs

Association between SARS-CoV-2 Omicron viral load and vaccination history

Association between SARS-CoV-2 Omicron viral load and vaccination history

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

Antibody response to Pfizer-BioNTech COVID-19 vaccine over 6 months

Polyethylene glycol-specific antibody responses induced by mRNA-1273 COVID-19 vaccine

Polyethylene glycol-specific antibody responses induced by mRNA-1273 COVID-19 vaccine

Exploring the vaccine effectiveness of COVID-19 booster vaccine doses

Exploring the vaccine effectiveness of COVID-19 booster vaccine doses

Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

Study explores SARS-CoV-2 Omicron variant and infected colon epithelial cells

Study demonstrates subset of vaccine-induced HLA-A*24:02-restricted T cells exhibits enhanced reactivity against the Omicron BA.1 variant

Study demonstrates subset of vaccine-induced HLA-A*24:02-restricted T cells exhibits enhanced reactivity against the Omicron BA.1 variant

Persistent loss of smell after COVID-19 associated with altered olfactory epithelial gene expression

Persistent loss of smell after COVID-19 associated with altered olfactory epithelial gene expression

Study evaluates the ocular tropism and the possible ocular transmission of SARS-CoV-2 in animal models

Study evaluates the ocular tropism and the possible ocular transmission of SARS-CoV-2 in animal models

The epidemiological features of SARS-CoV-2 infections in the fifth wave in Hong Kong

The epidemiological features of SARS-CoV-2 infections in the fifth wave in Hong Kong

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.